K21 Compound, a Potent Antifungal Agent: Implications for the Treatment of Fluconazole-Resistant HIV-Associated Candida Species
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Microbiology (2019) 10:1021. https://doi.org/10.3389/fmicb.2019.01021
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2024
- Urheber
-
John, Cathy N.
Abrantes, Pedro M. D. S.
Prusty, Bhupesh K.
Ablashi, Dharam V.
Africa, Charlene W. J.
- DOI
-
10.3389/fmicb.2019.01021
- URN
-
urn:nbn:de:bvb:20-opus-323505
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- John, Cathy N.
- Abrantes, Pedro M. D. S.
- Prusty, Bhupesh K.
- Ablashi, Dharam V.
- Africa, Charlene W. J.
- Universität Würzburg
Entstanden
- 2024
Ähnliche Objekte (12)
Hydrogel Containing PEG-Coated Fluconazole Nanoparticles with Enhanced Solubility and Antifungal Activity
Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
Ausbau der K21
Ausbau der K21
Ausbau der K21
Ausbau der K21
A Study of Clearance of Infection in HIV-Associated Cryptococcal Meningitis after Amphotericin-Based Induction and Fluconazole-Based Consolidation Therapy
Fluconazole-Niosome-Laden Contact Lens: A Promising Therapeutic Approach for Prolonged Ocular Delivery and Enhanced Antifungal Activity
Kesselumbau K.21 Montagebild, Rostansicht
Karten und Skizzen: K1 - K21
Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole
Synergistic and potential antifungal properties of tailored, one pot multicomponent monoterpenes co-delivered with fluconazole encapsulated nanostructure lipid carrier
Hydrogel Containing PEG-Coated Fluconazole Nanoparticles with Enhanced Solubility and Antifungal Activity
Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
Ausbau der K21
Ausbau der K21
Ausbau der K21
Ausbau der K21
A Study of Clearance of Infection in HIV-Associated Cryptococcal Meningitis after Amphotericin-Based Induction and Fluconazole-Based Consolidation Therapy
Fluconazole-Niosome-Laden Contact Lens: A Promising Therapeutic Approach for Prolonged Ocular Delivery and Enhanced Antifungal Activity
Kesselumbau K.21 Montagebild, Rostansicht
Karten und Skizzen: K1 - K21
Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole
Synergistic and potential antifungal properties of tailored, one pot multicomponent monoterpenes co-delivered with fluconazole encapsulated nanostructure lipid carrier
Hydrogel Containing PEG-Coated Fluconazole Nanoparticles with Enhanced Solubility and Antifungal Activity
Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
Ausbau der K21
Ausbau der K21
Ausbau der K21
Ausbau der K21
A Study of Clearance of Infection in HIV-Associated Cryptococcal Meningitis after Amphotericin-Based Induction and Fluconazole-Based Consolidation Therapy
Fluconazole-Niosome-Laden Contact Lens: A Promising Therapeutic Approach for Prolonged Ocular Delivery and Enhanced Antifungal Activity
Kesselumbau K.21 Montagebild, Rostansicht
Karten und Skizzen: K1 - K21
Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole